Kim MM, Aryal MP, Suresh K, Rosen BS, et al. A phase II study of multiparametric MR-guided high-dose response-adaptive radiotherapy with concurrent temozolomide in patients with newly diagnosed glioblastoma: Results from an interim analysis. Int J Radiat Oncol Biol Phys 2025 Mar 7:S0360-3016(25)00160.
PMID: 40058709